Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: An exploratory analysis of the outcomes of elderly patients in the RECORD-1 trial
Carcinoma, Renal Cell
Molecular Targeted Therapy
Protein Kinase Inhibitors
TOR Serine-Threonine Kinases
Everolimus is effective and tolerable in elderly patients with mRCC. When selecting targeted therapies in these patients, the specific toxicity profile of each agent and any patient comorbidities should be considered.